Navya Biologicals

Hubli, India Founded: 2006 • Age: 20 yrs
Biologics are developed via engineered yeast and MAb production platforms.
Annual revenue $581,598 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Navya Biologicals

Navya Biologicals is a company based in Hubli (India) founded in 2006. Navya Biologicals operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.

  • Headquarter Hubli, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Navya Biologicals Private Limited
  • Date of Incorporation 08 Jun, 2006
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $581.6 K (USD)
    107.59
    as on Mar 31, 2016
  • Net Profit
    $113.93 K (USD)
    268.91
    as on Mar 31, 2016
  • EBITDA
    $206.52 K (USD)
    3648.23
    as on Mar 31, 2016
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Navya Biologicals

Premium access

Detailed funding history for Navya Biologicals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Navya Biologicals

Investments
Premium access

Investment portfolio details for Navya Biologicals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Navya Biologicals

Premium access

Detailed financials for Navya Biologicals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Navya Biologicals Comparisons

Navya Biologicals Primary company
Description
Biologics are developed via engineered yeast and MAb product...
Location
Hubli, India
Founded Year
2006
Annual Revenue
$581.6 K (USD)
Net Profit
$113.93 K (USD)
EBITDA
$206.52 K (USD)
Employees
Not available
Premium access

Peer comparison for Navya Biologicals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Navya Biologicals

Navya Biologicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services are provided to biopharma sector.
Locked Locked Locked
Cancer and CVMD drugs are developed using PDX models.
Locked Locked Locked
Drug discovery services are provided for therapeutic development.
Locked Locked Locked
Drug discovery CRO company for epigenetic research and inflammatory diseases
Locked Locked Locked
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Drug discovery and development research services are provided.
Premium access

Detailed competitors of Navya Biologicals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Navya Biologicals

Premium access

Complete news archive for Navya Biologicals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navya Biologicals

Navya Biologicals was founded in 2006.

Navya Biologicals is headquartered in Hubli, India. It is registered at Hubli, Karnataka, India.

Rajyashri Ramakrishna is the current CEO of Navya Biologicals.

Annual revenue of Navya Biologicals is $581.6K as on Mar 31, 2016.

Navya Biologicals is biotechnology initiative focussed on the development protein-based biologics using its technology platforms. Its products are developed based on its platforms YeXtreme, the pathway engineered yeast platform for expression of complex peptides and proteins and ContiMAb, the MAb production platform. Its product pipeline currently includes 11 products with the lead product NAV-001 for autoimmune disorders is about to start Human clinical studies. Its other pipeline products have applications in Oncology, infertility, IBD and Myocardial Infraction. It also provided NavAlbumin, a recombinant Human Albumin. The company was funded by DBT and was a successful SBIRI applicant.

Navya Biologicals's top competitors include Evotec, Crown Bioscience and NIH.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available